Exgraft is a fully synthetic ePTFE (expandable) vascular graft.
The device combines the performance of ePTFE with the addition of a new radio-opaque design.
This first-class combination improves visibility of graft placement and orientation during surgery and follow-up.
The first ePTFE vascular graft characterized by:
Radiopaque markers on the outer surface for better visualization by X-ray, CT, post-implant fluoroscopy.
Controlled and minimally invasive expandability using standard techniques (angioplasty balloon).
Growth potential for pediatrics without the need for repeated surgery to replace grafts.
Increase of the original diameter of the inner lumen of the conduit following balloon angioplasty, to delay or reduce the incidence of restenosis
Radiopaque markers improve the display of:
Positioning and orientation of the graft
Twisting and bending
Original inner diameter marked with a number
Current diameter calculated using radiopaque circular signs
Founded in 2012, it is a spin-off of Carnegie Mellon University and Pittsburgh University.
Their passion is the development of advanced devices for cardiothoracic and vascular surgery.